Litcius/Paper detail

Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials

Fengcai Zhu, Hao Zeng, Jingxin Li, Bin Wang, Fanyue Meng, Feng Yang, Jiang Gu, Haoyu Liang, Yuemei Hu, Pei Liu, Liu‐sheng Peng, Xiao-Kui Hu, Yuan Zhuang, Min Fan, Haibo Li, Zhongming Tan, Ping Luo, Peng Zhang, Kai Chu, Jinyong Zhang, Ming Zeng, Quanming Zou

2022Vaccine24 citationsDOI

Topics & Concepts

MedicineImmunogenicityAdverse effectVaccinationStaphylococcus aureusPlaceboImmunologyAntigenRandomized controlled trialClinical endpointAntibodyInternal medicineImmune systemAntibioticsStaphylococcal infectionsMicrobiologyBiologyAlternative medicinePathologyGeneticsBacteriaAntimicrobial Resistance in StaphylococcusImmune Response and InflammationBiochemical and Structural Characterization
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials | Litcius